Renke Dai

1.4k total citations
44 papers, 1.2k citations indexed

About

Renke Dai is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Renke Dai has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmacology, 18 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Renke Dai's work include Pharmacogenetics and Drug Metabolism (20 papers), Drug Transport and Resistance Mechanisms (9 papers) and Analytical Chemistry and Chromatography (8 papers). Renke Dai is often cited by papers focused on Pharmacogenetics and Drug Metabolism (20 papers), Drug Transport and Resistance Mechanisms (9 papers) and Analytical Chemistry and Chromatography (8 papers). Renke Dai collaborates with scholars based in United States, China and Bahrain. Renke Dai's co-authors include Fred K. Friedman, Magang Shou, Thomas H. Rushmore, Thomas A. Baillie, Robert E. Vestal, Suoping Zhai, Mei Qin, Aiming Liu, Frank J. Gonzalez and Dan Cui and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Biochemical Journal.

In The Last Decade

Renke Dai

44 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renke Dai United States 20 559 451 247 166 153 44 1.2k
Heng‐Keang Lim United States 19 562 1.0× 436 1.0× 270 1.1× 332 2.0× 132 0.9× 33 1.2k
Jouko Uusitalo Finland 18 547 1.0× 350 0.8× 243 1.0× 173 1.0× 103 0.7× 23 1.1k
JoAnn Scatina United States 22 681 1.2× 483 1.1× 318 1.3× 210 1.3× 90 0.6× 56 1.6k
Jan L. Wahlstrom United States 22 729 1.3× 348 0.8× 354 1.4× 99 0.6× 187 1.2× 47 1.3k
David J. Rance United Kingdom 15 834 1.5× 636 1.4× 452 1.8× 178 1.1× 216 1.4× 18 1.7k
John C. L. Erve United States 17 367 0.7× 371 0.8× 140 0.6× 226 1.4× 116 0.8× 26 1.0k
T. S. Tracy United States 15 726 1.3× 255 0.6× 375 1.5× 171 1.0× 155 1.0× 22 1.1k
R. Foti United States 21 680 1.2× 408 0.9× 373 1.5× 80 0.5× 146 1.0× 51 1.3k
J. Matthew Hutzler United States 22 1.0k 1.9× 443 1.0× 501 2.0× 179 1.1× 238 1.6× 34 1.5k
Viviane Meunier France 8 507 0.9× 308 0.7× 396 1.6× 82 0.5× 72 0.5× 9 1.1k

Countries citing papers authored by Renke Dai

Since Specialization
Citations

This map shows the geographic impact of Renke Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renke Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renke Dai more than expected).

Fields of papers citing papers by Renke Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renke Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renke Dai. The network helps show where Renke Dai may publish in the future.

Co-authorship network of co-authors of Renke Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Renke Dai. A scholar is included among the top collaborators of Renke Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renke Dai. Renke Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Weifan, et al.. (2021). Influence of two-period cross-over design on the bioequivalence study of gefitinib tablets in beagle dogs. European Journal of Pharmaceutical Sciences. 165. 105933–105933. 1 indexed citations
2.
Jiang, Weifan, et al.. (2020). Roles of diclofenac and its metabolites in immune activation associated with acute hepatotoxicity in TgCYP3A4/hPXR-humanized mice. International Immunopharmacology. 86. 106723–106723. 10 indexed citations
3.
Jiang, Weifan, et al.. (2019). Studies of pharmacokinetics in beagle dogs and drug-drug interaction potential of a novel selective ZAK inhibitor 3h for hypertrophic cardiomyopathy treatment. Journal of Pharmaceutical and Biomedical Analysis. 172. 206–213. 2 indexed citations
4.
He, Changsheng, Xinyi Du, Hai‐jie Wang, et al.. (2018). Advancing the predictivity of skin sensitization by applying a novel HMOX1 reporter system. Archives of Toxicology. 92(10). 3103–3115. 7 indexed citations
5.
Jiang, Weifan, et al.. (2018). Comparison of in vitro/in vivo blood distribution and pharmacokinetics of artemisinin, artemether and dihydroartemisinin in rats. Journal of Pharmaceutical and Biomedical Analysis. 162. 140–148. 22 indexed citations
6.
Guo, Jiayin, et al.. (2015). Determination of a novel dipeptidyl peptidase IV inhibitor in monkey plasma by HPLC–MS/MS and its application in a pharmacokinetics study. Journal of Pharmaceutical and Biomedical Analysis. 117. 99–103. 10 indexed citations
7.
Liu, Aiming, Julin Yang, Xin Zhao, et al.. (2011). Induction of P450 3A1/2 and 2C6 by gemfibrozil in Sprague-Dawley rats. Pharmacological Reports. 63(1). 157–164. 9 indexed citations
8.
Peng, Li, Guicheng Zhang, Xiaobing Lan, et al.. (2010). The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes. European Journal of Medicinal Chemistry. 46(1). 71–76. 43 indexed citations
9.
Zhu, Lin, et al.. (2009). Simultaneous analysis of bambuterol and its active metabolite terbutaline enantiomers in rat plasma by chiral liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 52(2). 227–231. 33 indexed citations
10.
Liu, Aiming, Andrew D. Patterson, Xinying Zhang, et al.. (2009). Fenofibrate Metabolism in the Cynomolgus Monkey using Ultraperformance Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry-Based Metabolomics. Drug Metabolism and Disposition. 37(6). 1157–1163. 25 indexed citations
11.
Liu, Aiming, et al.. (2008). Myotoxicity of gemfibrozil in Cynomolgus monkey model and its relationship to pharmacokinetic properties. Toxicology and Applied Pharmacology. 235(3). 287–295. 8 indexed citations
12.
Zhu, Mingshe, Weiping Zhao, Humberto R. Jimenez, et al.. (2005). CYTOCHROME P450 3A-MEDIATED METABOLISM OF BUSPIRONE IN HUMAN LIVER MICROSOMES. Drug Metabolism and Disposition. 33(4). 500–507. 58 indexed citations
13.
Hadjokas, Nicholas, Renke Dai, Fred K. Friedman, et al.. (2002). Arginine to lysine 108 substitution in recombinant CYP1A2 abolishes methoxyresorufin metabolism in lymphoblastoid cells. British Journal of Pharmacology. 136(3). 347–352. 16 indexed citations
14.
Shou, Magang, Renke Dai, Dan Cui, et al.. (2001). A Kinetic Model for the Metabolic Interaction of Two Substrates at the Active Site of Cytochrome P450 3A4. Journal of Biological Chemistry. 276(3). 2256–2262. 101 indexed citations
15.
Sapone, Andrea, Jeffrey M. Peters, Shuichi Sakai, et al.. (2000). The human peroxisome proliferator-activated receptor ?? gene: identification and functional characterization of two natural allelic variants. Pharmacogenetics. 10(4). 321–333. 103 indexed citations
16.
Wei, Xiaoxiong, Renke Dai, Suoping Zhai, et al.. (1999). Inhibition of Human Liver Cytochrome P-450 1A2 by the Class IB Antiarrhythmics Mexiletine, Lidocaine, and Tocainide. Journal of Pharmacology and Experimental Therapeutics. 289(2). 853–858. 15 indexed citations
17.
Zhai, Suoping, Renke Dai, Xiaoxiong Wei, Fred K. Friedman, & Robert E. Vestal. (1998). Inhibition of methoxyresorufin demethylase activity by flavonoids in human liver microsomes. Life Sciences. 63(8). PL119–PL123. 19 indexed citations
18.
Dai, Renke, Suoping Zhai, Xiaoxiong Wei, et al.. (1998). Inhibition of human cytochrome P450 1A2 by flavones: A molecular modeling study. Journal of Protein Chemistry. 17(7). 643–650. 27 indexed citations
19.
Dai, Renke, et al.. (1995). Initial spectroscopic characterization of the ciliate photoreceptor stentorin. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1231(1). 58–68. 15 indexed citations
20.
Yamazaki, Tomoko, Iwao Yamazaki, Yukio Nishimura, Renke Dai, & Pill‐Soon Song. (1993). Time-resolved fluorescence spectroscopy and photolysis of the photoreceptor blepharismin. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1143(3). 319–326. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heng‐Keang Lim Breakdown of academic impact, for papers by Jouko Uusitalo Breakdown of academic impact, for papers by JoAnn Scatina Breakdown of academic impact, for papers by Jan L. Wahlstrom Breakdown of academic impact, for papers by David J. Rance Breakdown of academic impact, for papers by John C. L. Erve Breakdown of academic impact, for papers by T. S. Tracy Breakdown of academic impact, for papers by R. Foti Breakdown of academic impact, for papers by J. Matthew Hutzler Breakdown of academic impact, for papers by Viviane Meunier
Rankless by CCL
2026